Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Intellectual Property and Trade

  • your selections
Clear Search

Filter Results

date

Tags

  • results
South Africa Publishes Draft Intellectual Property Policy With Potential Effects For Pharma Patents

“South Africa’s government has published a draft intellectual property policy with potential far-reaching effects for pharmaceutical patents, which rights groups hailed Monday as a move towards lower medicine costs,” Agence France-Presse reports. “If accepted, the reforms will facilitate the production of cheaper, generic medicines, according to Doctors Without Borders (MSF)…

CFR Blog Examines Debate Over TPP Tobacco Regulation Proposals

In a Council on Foreign Relations (CFR) “Expert Brief,” Thomas Bollyky, a CFR senior fellow for global health, economics, and development, examines debate over the treatment of tobacco under the Trans-Pacific Partnership (TPP), “the pending trade deal between the United States and eleven other countries.” He continues, “The White House…

Report Examines Intersection Of Human Rights, Health And Intellectual Property

The Center for Global Health Policy’s “Science Speaks” blog highlights a paper (.pdf) from Yale’s Global Health Justice Partnership, a joint initiative of Yale Law School and Yale School of Public Health, in which the authors “seek to counter the weight given to intellectual property rights with human rights laws,…

Honduras, Ukraine Challenge Australian Laws On Tobacco Marketing At WTO

“Ukraine and Honduras are reviving a dispute at the World Trade Organization (WTO) challenging Australian laws that impose uniform drab green packaging and large graphic health warnings for cigarettes, diplomats said on Friday,” Reuters reports. “Tobacco firms say the Australian rules, which outlaw logos, infringe their trademarks,” the news agency…

TPP Should Address U.S. Business Concerns But Address Health Risks Of Tobacco

“Tobacco sickens and, eventually, can kill if consumed as intended. Every country, the United States included, should be taking every effective step to prevent smoking,” a Washington Post editorial states. The U.S. “has wisely pursued pacts to expand free trade with partners around the world,” but “[w]hat to do ……

U.N. Report Gives Mixed Review Of MDG 8 On Partnerships, Trade

“The international community must live up to the commitments it made in support of achieving universally accepted anti-poverty targets, [U.N.] Secretary-General Ban Ki-moon [on Thursday] said launching a new report [.pdf] which finds that despite significant successes, the global economic slowdown continues to hinder progress on the Millennium Development Goals…

Indonesia To Issue Compulsory Licenses For HIV, Hepatitis B Drugs Still Under Patent

“The Indonesian government hopes to implement one of the largest ever examples of ‘compulsory licensing,’ which will enable the generic manufacture of drugs still under patent,” IRIN reports. “Under the World Trade Organization’s Trade Related Aspects of Intellectual Property Rights (TRIPS), countries can override patents for public health purposes by…

India’s Supreme Court Rules Against Novartis AG In ‘Landmark’ Patent Case

“India’s Supreme Court on Monday rejected drug maker Novartis AG’s attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines,” the Associated Press reports. “Novartis had…

Reuters Examines Implications Of India’s Novartis Patent Ruling For Big Pharma

Reuters examines the implications of India’s Supreme Court ruling to overturn a patent on Novartis’s cancer treatment Glivec for the pharmaceutical industry in India and across the developing world. “Stung by a landmark patent defeat, Western drug makers will be wary about launching new products in India, but they cannot…

Five Japanese Drug Makers Form PPP To Accelerate Development Of Drugs, Vaccines For Infectious Diseases

“Five Japanese pharmaceutical giants are teaming up with the Bill & Melinda Gates Foundation and Japan’s government to develop new medicines, vaccines, and diagnostics for infectious diseases in developing countries,” GENNews reports (4/8). “The Global Health Innovative Technology (GHIT) fund will see Takeda, Astellas, Daiichi-Sankyo, Eisai and Shionogi partner with [the] non-profit…